1. Home
  2. XENE vs HUT Comparison

XENE vs HUT Comparison

Compare XENE & HUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • HUT
  • Stock Information
  • Founded
  • XENE 1996
  • HUT 2011
  • Country
  • XENE Canada
  • HUT United States
  • Employees
  • XENE N/A
  • HUT N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • HUT Finance: Consumer Services
  • Sector
  • XENE Health Care
  • HUT Finance
  • Exchange
  • XENE Nasdaq
  • HUT Nasdaq
  • Market Cap
  • XENE 2.9B
  • HUT 2.7B
  • IPO Year
  • XENE 2014
  • HUT N/A
  • Fundamental
  • Price
  • XENE $36.70
  • HUT $37.79
  • Analyst Decision
  • XENE Strong Buy
  • HUT Strong Buy
  • Analyst Count
  • XENE 11
  • HUT 14
  • Target Price
  • XENE $52.73
  • HUT $31.21
  • AVG Volume (30 Days)
  • XENE 636.6K
  • HUT 5.7M
  • Earning Date
  • XENE 11-11-2025
  • HUT 11-12-2025
  • Dividend Yield
  • XENE N/A
  • HUT N/A
  • EPS Growth
  • XENE N/A
  • HUT N/A
  • EPS
  • XENE N/A
  • HUT 1.48
  • Revenue
  • XENE $7,500,000.00
  • HUT $138,543,000.00
  • Revenue This Year
  • XENE N/A
  • HUT $74.79
  • Revenue Next Year
  • XENE $207.88
  • HUT $116.78
  • P/E Ratio
  • XENE N/A
  • HUT $25.78
  • Revenue Growth
  • XENE N/A
  • HUT N/A
  • 52 Week Low
  • XENE $26.74
  • HUT $10.04
  • 52 Week High
  • XENE $46.00
  • HUT $38.31
  • Technical
  • Relative Strength Index (RSI)
  • XENE 49.37
  • HUT 83.05
  • Support Level
  • XENE $35.60
  • HUT $24.20
  • Resistance Level
  • XENE $39.55
  • HUT $28.66
  • Average True Range (ATR)
  • XENE 1.04
  • HUT 2.08
  • MACD
  • XENE -0.49
  • HUT 0.95
  • Stochastic Oscillator
  • XENE 25.94
  • HUT 96.04

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

Share on Social Networks: